tag:blogger.com,1999:blog-41151876987331666912024-02-08T07:37:31.198+01:00DeltaPatents EQE Paper B ChAs of EQE 2017, the B e/m and B Ch papers have merged into one paper. This seperate B Ch blog has been discontinued.Roel van Woudenberghttp://www.blogger.com/profile/15823355175016282250noreply@blogger.comBlogger8125tag:blogger.com,1999:blog-4115187698733166691.post-63086924446653388582021-02-04T09:50:00.001+01:002021-02-04T09:50:00.762+01:00Mock 2's Paper B (4 Feb 2021)<blockquote style="border: none; margin: 0 0 0 40px; padding: 0px;"><p style="text-align: left;"> <span style="font-family: inherit;">"</span><span style="background-color: white; color: #0b2a43; font-family: inherit;">To allow candidates to test the system also close to the real examination conditions, a second mock (Mock 2) is planned for the week of 1 to 5 February 2021. The examination papers will take place during that week at the same week days and times as the real examination, see </span><a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/66EB601464EC7BECC12586320050164F/$FILE/ExamPapers%20EQE%202021_EN.pdf" style="background-color: white; background-image: url("../images/icon_sprite.gif"); background-repeat: no-repeat; box-sizing: border-box; color: #0b2a43; cursor: pointer; font-family: inherit;" target="_blank">here</a><span style="background-color: white; color: #0b2a43; font-family: inherit;">.</span><span style="font-family: inherit;">" (see <a href="https://www.epo.org/learning/eqe/e-eqe.html" target="_blank">e-EQE webpage</a>)</span></p></blockquote><p><span style="font-family: inherit;"><b><span style="color: #990000;">Today</span></b>, 4 February 2021, <b><span style="color: #990000;">Paper B of Mock 2 was organized</span></b>, using the Wiseflow platform </span>which will be used for the e-EQE 2021 in the week of 1-5 March 2021<span style="font-family: inherit;">.</span></p><p><b><span style="color: #990000;">Please share your experiences with the platform, as well as any comments to the paper.</span></b></p><div><i>We allow you to post your comments anonymously, but it is <span style="color: #990000;"><b>recommended and appreciated if you identify yourself using your true name or a nick name</b> </span>- that makes communication much more pleasant and efficient than talking to "Anonymous 19 January 2021 22:23" and alike. </i></div><div><i>Please refer to the "Problems with commenting" link on the top right of this blog page if you have problems with commenting (which may occur due to security settings, cookies, etc, esp when using Captcha with anonymous posts).</i></div>Roel van Woudenberghttp://www.blogger.com/profile/15823355175016282250noreply@blogger.comtag:blogger.com,1999:blog-4115187698733166691.post-11569590598467009432017-02-17T10:59:00.000+01:002017-02-17T10:59:08.758+01:00Blog Paper B one-for-allOur blog for the new, single Paper B can be found <a href="http://eqe-b-em.blogspot.nl/" target="_blank">here</a>Roel van Woudenberghttp://www.blogger.com/profile/15823355175016282250noreply@blogger.comtag:blogger.com,1999:blog-4115187698733166691.post-72412743987509463992016-06-20T09:33:00.003+02:002016-06-20T09:33:51.902+02:00Examination Papers A and B – Examination Board made mock papers available<div class="MsoNormal">
<span style="font-family: inherit;"><span lang="EN-US"> </span><span lang="EN-US" style="background: white; color: #0b2a43;">With effect from 2017, a single Paper
A and a single Paper B will be set each year. As for current Paper C and the
Pre-Examination, Papers A and B will be set in technical fields that are
accessible to everyone. The Examination Board has made mock papers available
for<span class="apple-converted-space"> </span></span><span style="background: white; color: #0b2a43;"><a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/e1558f38ad0987cbc1257f780055e08d/$FILE/MockPaperA.pdf" target="_blank"><b><span lang="EN-US" style="color: #0b2a43; mso-ansi-language: EN-US;">Paper A</span></b></a></span><span class="apple-converted-space"><span lang="EN-US" style="background: white; color: #0b2a43;"> </span></span><span lang="EN-US" style="background: white; color: #0b2a43;">(</span><span style="background: white; color: #0b2a43;"><a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/603e34c657386decc1257fa200300dbf/$FILE/ExReport_MockA.pdf" style="box-sizing: border-box; cursor: pointer;"><b><i><span lang="EN-US" style="color: #0b2a43; mso-ansi-language: EN-US;">examiner report</span></i></b></a></span><span lang="EN-US" style="background: white; color: #0b2a43;">) and<span class="apple-converted-space"> </span></span><span style="background: white; color: #0b2a43;"><a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/e1558f38ad0987cbc1257f780055e08d/$FILE/MockPaperB.pdf" style="box-sizing: border-box; cursor: pointer;" target="_blank"><b><span lang="EN-US" style="color: #0b2a43; mso-ansi-language: EN-US;">Paper B</span></b></a></span><span class="apple-converted-space"><span lang="EN-US" style="background: white; color: #0b2a43;"> </span></span><span lang="EN-US" style="background: white; color: #0b2a43;">(</span><span style="background: white; color: #0b2a43;"><a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/603e34c657386decc1257fa200300dbf/$FILE/ExReport_MockB.pdf" style="box-sizing: border-box; cursor: pointer;"><b><i><span lang="EN-US" style="color: #0b2a43; mso-ansi-language: EN-US;">examiner report</span></i></b></a></span><span lang="EN-US" style="background: white; color: #0b2a43;">). The examiner reports are currently available in English
only.</span></span></div>
Roel van Woudenberghttp://www.blogger.com/profile/15823355175016282250noreply@blogger.comtag:blogger.com,1999:blog-4115187698733166691.post-2346050964012543702016-03-02T14:30:00.000+01:002016-03-22T13:10:48.566+01:00B-Chemistry 2016: First impressions?<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjs5WIZGskqui8zZcoDYvJSzePiRIVmGlbB6sj2X1RquEfjykFBds56OVW8Jif43You-Yy2ZSJV1T2lEO-7BM015uKEwVHW4qndfWoop77AzC7Rp5nY9pBh92-aqj5zT5zyUAklEXSPIuI/s1600/B-Ch+2016+cover+page+mock.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjs5WIZGskqui8zZcoDYvJSzePiRIVmGlbB6sj2X1RquEfjykFBds56OVW8Jif43You-Yy2ZSJV1T2lEO-7BM015uKEwVHW4qndfWoop77AzC7Rp5nY9pBh92-aqj5zT5zyUAklEXSPIuI/s1600/B-Ch+2016+cover+page+mock.jpg" width="228" /></a></div>
<div style="margin: 0cm;">
<span style="font-family: inherit;"><strong><i><span lang="EN-US"><br /></span></i></strong></span></div>
<div style="margin: 0cm;">
<span style="font-family: inherit;"><strong><i><span lang="EN-US">To all who sat the B-paper today:</span></i></strong><span lang="EN-US"><u1:p></u1:p><o:p></o:p></span></span></div>
<div style="margin: 0cm 0cm 0pt;">
<br /></div>
<div style="margin: 0cm 0cm 0pt;">
<span lang="EN-US"><span style="font-family: inherit;">What are your first impressions to this year's B-paper? <o:p></o:p></span></span></div>
<div style="margin: 0cm;">
<span style="font-family: inherit;"><span lang="EN-US">Any
general or specific comments?</span><span lang="EN-US"><o:p></o:p></span></span></div>
<div style="margin: 0cm 0cm 0pt;">
<br /></div>
<div style="margin: 0cm 0cm 0pt;">
<span lang="EN-US"><span style="font-family: inherit;">How many marks do you expect to have scored?<o:p></o:p></span></span></div>
<div style="margin: 0cm;">
<span style="font-family: inherit;"><span lang="EN-US">What
is your expectation of the pass rate and the average score?</span><span lang="EN-US"><o:p></o:p></span></span></div>
<div style="margin: 0cm;">
<span style="font-family: inherit;"><span lang="EN-US">How
did this year's paper compare to the 2014 and 2015 papers (assuming your
practiced those)</span><span lang="EN-US"><o:p></o:p></span></span></div>
<div style="margin: 0cm 0cm 0pt;">
<div style="margin: 0cm 0cm 0pt;">
<span style="font-family: inherit;"><span lang="EN-US"></span></span><br />
<strong><em>The paper</em></strong><br />
<span style="font-family: inherit;"><span lang="EN-US">Copies of the paper are available <a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/9a0a9ddfaed4f552c1257f6c0043e3fd/$FILE/BCh2016_EN.pdf">here</a></span></span></div>
<div style="margin: 0cm 0cm 0pt;">
<em></em><br />
<strong><em>This blog</em></strong><br />
<span lang="EN-US"><span style="font-family: inherit;"><em>We are sorry to inform you that will not post answer to the B chemistry paper ourselves his year.</em></span></span><br />
</div>
We do however want to give all chemistry candidates the opportunity to discuss the papers ands their answers here.<br />
<div style="margin: 0cm;">
<br /></div>
<div style="margin: 0cm 0cm 0pt;">
<span style="font-family: inherit;"><strong><i><span lang="EN-US">We look forward to your comments!</span></i></strong><span lang="EN-US"><u1:p></u1:p><o:p></o:p></span></span></div>
<div style="margin: 0cm 0cm 0pt;">
<span style="font-family: inherit;"><span lang="EN-US" style="background: white;">Comments are welcome in any official EPO language, not just English. So, <b><i>comments in German and French are also very welcome</i></b>!</span><span lang="EN-US"><u1:p></u1:p><o:p></o:p></span></span></div>
<div style="margin: 0cm 0cm 0pt;">
<br /></div>
<div style="margin: 0cm 0cm 0pt;">
<span style="font-family: inherit;"><span lang="EN-US">Please do not post your comments anonymously - it is allowed, but it makes responding more difficult and rather clumsy ("Dear Mr/Mrs/Ms Anonymous of 03-03-2015 03:03"), whereas using your real name or a pseudonym is more personal, more interesting and makes a more attractive conversation.<span class="apple-converted-space"> </span>You do not need to log in or make an account - it is OK to just put your (nick) name at the end of your post.</span><span lang="EN-US"><o:p></o:p></span></span></div>
<div style="margin: 0cm 0cm 0pt;">
<br /></div>
<div style="margin: 0cm 0cm 0pt;">
<span style="font-family: inherit;"><span lang="EN-US">Please post your comments as to <strong>first impressions, </strong><strong>general remarks</strong> as well as <strong>any details about the paper and your answer</strong>. Feel also free to discuss your answers</span></span><span lang="EN-US"><span style="font-family: inherit;">.</span></span><br />
<span lang="EN-US"><span style="font-family: inherit;"> <o:p></o:p></span></span></div>
<div style="margin: 0cm;">
<span style="font-family: inherit;"><span lang="EN-US">Thanks!</span><span lang="EN-US"><o:p></o:p></span></span></div>
</div>
DeltaPatents EQE Blogshttp://www.blogger.com/profile/13926591520841144736noreply@blogger.comtag:blogger.com,1999:blog-4115187698733166691.post-87218864646808307272015-07-02T16:31:00.001+02:002015-07-02T16:31:37.106+02:00Results Main Exam EQE 2015 now available!<div style="margin-bottom: .0001pt; margin: 0cm;">
<span style="font-family: inherit;"><span style="background: white;">Today, 2 July 2015, the results from the EQE Main
Exam 2015 were made available on the EQE webpages (</span><a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/833E9CC22475C968C1257E7600320C80/$File/2015_MainEx_ResultsOnline.pdf" target="_blank">pdf</a><span style="background: white;">),
as a list showing the marks per EQE regnr. The pdf-file also indicates that the
official results letters will be dispatched as of 14 July onwards, and that
only the results as notified in the official results letter are legally binding.</span><o:p></o:p></span></div>
<div style="margin-bottom: .0001pt; margin: 0cm;">
<br /></div>
<span style="font-family: inherit;"><u1:p></u1:p>
</span><br />
<div style="margin-bottom: .0001pt; margin: 0cm;">
<span style="font-family: inherit;">Pass rates for each of the papers papers and score distributions
are presented in our general EQE blog: <a href="http://eqe-deltapatents.blogspot.nl/">http://eqe-deltapatents.blogspot.nl/</a></span><span style="font-size: 13.5pt;"><o:p></o:p></span></div>
<div style="margin-bottom: .0001pt; margin: 0cm;">
<br /></div>
Roel van Woudenberghttp://www.blogger.com/profile/15823355175016282250noreply@blogger.comtag:blogger.com,1999:blog-4115187698733166691.post-6506599134710462192015-03-03T16:15:00.001+01:002015-03-05T11:11:39.846+01:00Our comments to B Chemistry 2015 (airbag compositions)<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhl-Wiss2PZsiSQvoTTtL8wm0BvhsqArTOLLsCrg2Ns77mypRwbAhKZqydNTbKOHK5lTaAIdu0gzfmOKpmveBpis_thQNsbZ3Mjnf-_xQwfSMZp-9QVA-8GopHzRNX1TZQffn3A4a3BFuBL/s1600/B+2015+Table+2+(DE%2Bclean).jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhl-Wiss2PZsiSQvoTTtL8wm0BvhsqArTOLLsCrg2Ns77mypRwbAhKZqydNTbKOHK5lTaAIdu0gzfmOKpmveBpis_thQNsbZ3Mjnf-_xQwfSMZp-9QVA-8GopHzRNX1TZQffn3A4a3BFuBL/s1600/B+2015+Table+2+(DE%2Bclean).jpg" height="207" width="400" /></a></div>
<span style="font-family: inherit;">The Chemistry version of Paper B (<a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/503E14F9739DDF51C1257DFE005298C2/$File/Bch_2015_en.pdf" target="_blank">English</a>, <a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/503E14F9739DDF51C1257DFE005298C2/$File/Bch_2015_fr.pdf" target="_blank">French</a>, <a href="http://documents.epo.org/projects/babylon/eponot.nsf/0/503E14F9739DDF51C1257DFE005298C2/$File/BCh_2015_de.pdf" target="_blank">German</a>) addressed airbag compositions.</span><br />
<span style="font-family: inherit;"><br /></span>
<div class="MsoNormal">
<u><span lang="NL" style="font-family: inherit; line-height: 107%;">New
set of claims<o:p></o:p></span></u></div>
<ol>
<li><span style="font-family: inherit; line-height: 107%; text-indent: -18pt;">Airbag composition comprising,</span></li>
<ol type="i">
<li><span style="font-family: inherit; line-height: 107%; text-indent: -18pt;">20 to 50 wt.% of a fuel being selected from the group of tetrazole,
aminotetrazole, nitrotetrazole, nitroaminotetrazole and triazole;</span></li>
<li><span style="font-family: inherit; line-height: 107%;">30 to 70 wt.% of an oxidant being selected
from alkali metal or alkaline earth metal nitrate, chlorate or perchlorate;</span></li>
<li><span style="font-family: inherit; line-height: 107%;">10 to 20 wt. % of a slag forming agent
comprising a carbide of boron, aluminium or silicon, in which the slag forming
agent comprises hydrotalcite as a secondary slag forming agent which is added
in a weight ratio of 1:5 to 5:1 with respect to the carbide, and wherein the
fuel is in the form of fuel particles having a size of 5 to 80 µm.</span></li>
</ol>
<li><span style="font-family: inherit; line-height: 107%; text-indent: -18pt;">Airbag composition according to claim 1, wherein the
slag forming agent comprises a carbide of aluminium or silicon.</span></li>
<li><span style="font-family: inherit; line-height: 107%; text-indent: -18pt;">Process for making the airbag composition according to
claim 1 or 2 comprising the steps:</span></li>
<ol type="i">
<li><span style="font-family: inherit; line-height: 107%; text-indent: -18pt;">mixing the slag forming agent and hydrotalcite;</span></li>
<li><span style="font-family: inherit; line-height: 107%;">adding the other ingredients;</span></li>
<li><span style="font-family: inherit; line-height: 107%;">pressing for at least 5 minutes the mixture
as obtained in step (iii) into pellets;</span></li>
<li><span style="font-family: inherit; line-height: 107%;">heat treating the pellets at a temperature
between 80 and 120 ˚C for at least 10 hours.</span></li>
</ol>
<li><span style="font-family: inherit;"><span style="line-height: 107%; text-indent: -18pt;"><span style="font-stretch: normal; line-height: normal;"> </span></span><span style="line-height: 107%; text-indent: -18pt;">Airbag comprising the airbag compositions according to
claim 1 or 2.</span></span></li>
</ol>
<u><span lang="NL" style="font-family: inherit; line-height: 17.1200008392334px;">Amendments</span></u><br />
<u><span lang="NL" style="font-family: inherit; line-height: 17.1200008392334px;"><br /></span></u>
<span style="font-family: inherit;">The amendment in claim 1 as suggested by the Applicant finds no basis in the application as filed, since there is only basis for hydrotalcite in combination with a carbide as slag forming agent, not nitride. In this respect reference is made to original claim 3 and [011], lines 4-5 of the application as originally filed.</span><br />
<span style="font-family: inherit;"><br /></span>
<span style="font-family: inherit;">The same reasoning applies to the amended process claim.</span><br />
<br />
<div class="MsoNormal">
<i style="background-color: white; line-height: 20.7999992370605px;"><span style="font-family: inherit;">Looking forward to your comments!</span></i><br />
<i style="background-color: white; line-height: 20.7999992370605px;"><span style="font-family: inherit;"><br /></span></i>
<i style="font-family: inherit; line-height: 20.7999992370605px;">Note: if you do not have a google account, you can post using the "Anonymous" option. In that case, please sign the comment with your name -or a nickname if you do not want to give your real name.</i></div>
<div style="background-color: white; line-height: 20.7999992370605px;">
<span style="line-height: 20.7999992370605px;"><br /></span><span style="line-height: 14.9499998092651px;">Lex</span></div>
<div style="background-color: white;">
<span style="font-family: inherit;"><span style="line-height: 14.9499998092651px;"><br /></span></span><span style="font-family: inherit; line-height: 20.7999992370605px;"><span style="line-height: 20.7999992370605px;"><span style="line-height: 20.7999992370605px;">© </span><span style="line-height: 20.7999992370605px;">Copyright DeltaPatents, 2015</span></span></span><br />
<span style="font-family: inherit; line-height: 20.7999992370605px;">All rights reserved. No part of this answer may be reproduced, used in any way for generating further course material or updates, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written consent of DeltaPatents.</span><br />
<span style="font-family: inherit; line-height: 20.7999992370605px;">The answer is made available for personal use only.</span></div>
DeltaPatents EQE Blogshttp://www.blogger.com/profile/13926591520841144736noreply@blogger.comtag:blogger.com,1999:blog-4115187698733166691.post-71078293422131976202014-03-04T10:52:00.000+01:002014-03-06T14:00:27.741+01:00B-ch 2014: our amended claims<i>Our amended claims and considerations in their support are given below. A
disclaimer applies here; we have no more knowledge of the solution than any of
the candidates. So we may be on the wrong track. One should also
realize that your argumentation is worth most of the marks. </i><br />
<i><br /></i>
<i><b>Your comments are highly appreciated!</b></i><br />
<i><b><br /></b></i><span style="color: #1f497d;">Examen 2014 B ziet er relatief eenvoudig uit.</span><br />
<div class="MsoNormal" style="margin-top: 12.0pt;">
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">Op grond van de door de klant voorgestelde conclusies kan
het volgende worden ingediend:</span><br />
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;"><br /></span></div>
<div class="MsoListParagraph" style="line-height: 150%; margin-left: 32.2pt; mso-list: l0 level1 lfo1; text-autospace: none; text-indent: -18.0pt;">
<!--[if !supportLists]--><span style="font-family: "Arial","sans-serif"; mso-fareast-font-family: Arial;">1.<span style="font-family: 'Times New Roman'; font-size: 7pt; line-height: normal;">
</span></span><!--[endif]--><span style="font-family: "Arial","sans-serif";">Process
for the hydrogenation of edible oils in the presence of hydrogen a catalyst comprising a
solid support, precious metal nanoparticles having an average particle size of
1 to 12 nm, according to ASTM 99999/2000, and at least 0.1 wt% of a polymer
containing a heterocyclic group having at least one heteroatom.<o:p></o:p></span></div>
<div class="MsoListParagraph" style="line-height: 150%; margin-left: 32.2pt; mso-list: l0 level1 lfo1; text-autospace: none; text-indent: -18.0pt;">
<!--[if !supportLists]--><span style="font-family: "Arial","sans-serif"; mso-fareast-font-family: Arial;">2.<span style="font-family: 'Times New Roman'; font-size: 7pt; line-height: normal;">
</span></span><!--[endif]--><span style="font-family: "Arial","sans-serif";">The
process according to claim 1 wherein the heterocyclic group is a side group of
the polymer.<o:p></o:p></span></div>
<div class="MsoListParagraph" style="line-height: 150%; margin-left: 32.2pt; mso-list: l0 level1 lfo1; text-autospace: none; text-indent: -18.0pt;">
<!--[if !supportLists]--><span style="font-family: "Arial","sans-serif"; mso-fareast-font-family: Arial;">3.<span style="font-family: 'Times New Roman'; font-size: 7pt; line-height: normal;">
</span></span><!--[endif]--><span style="font-family: "Arial","sans-serif";">Process
according to claim 1 or 2 wherein the heteroatom is nitrogen.<o:p></o:p></span></div>
<div class="MsoListParagraph" style="line-height: 150%; margin-left: 32.2pt; mso-list: l0 level1 lfo1; text-autospace: none; text-indent: -18.0pt;">
<!--[if !supportLists]--><span style="font-family: "Arial","sans-serif"; mso-fareast-font-family: Arial;">4.<span style="font-family: 'Times New Roman'; font-size: 7pt; line-height: normal;">
</span></span><!--[endif]--><span style="font-family: "Arial","sans-serif";">Process
according to claim 1 to 3 wherein the polymer is polyvinylpyrrolidone.<o:p></o:p></span></div>
<div class="MsoListParagraph" style="line-height: 150%; margin-left: 32.2pt; mso-list: l0 level1 lfo1; text-autospace: none; text-indent: -18.0pt;">
<!--[if !supportLists]--><span style="font-family: "Arial","sans-serif"; mso-fareast-font-family: Arial;">5.<span style="font-family: 'Times New Roman'; font-size: 7pt; line-height: normal;">
</span></span><!--[endif]--><span style="font-family: "Arial","sans-serif";">Process
according to claims 1 to 4, wherein the edible oil is fish oil.<o:p></o:p></span></div>
<div class="MsoListParagraph" style="line-height: 150%; margin-left: 32.2pt; mso-list: l0 level1 lfo1; text-autospace: none; text-indent: -18.0pt;">
<!--[if !supportLists]--><span style="font-family: "Arial","sans-serif"; mso-fareast-font-family: Arial;">6.<span style="font-family: 'Times New Roman'; font-size: 7pt; line-height: normal;">
</span></span><!--[endif]--><span style="font-family: "Arial","sans-serif";">Process
according to claims 1 to 4, wherein the edible oil is soybean oil.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-top: 12.0pt;">
<br />
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;"><br /></span>
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">D1 betreft ww voor het verkrijgen van laag transgehalte.
Er wordt ook PVP gebruikt, echter als filterhulp. PVP heeft geen invloed op de
reactie. De deeltjesgrootte van het edelmetaal is niet geopenbaard. De reactietijd
is 3-4 uur<br />
D2 betreft ww met gebruik van nanodeeltjes. De reactietijd is kort. <o:p></o:p></span></div>
<div class="MsoNormal" style="margin-top: 12.0pt;">
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">Het doel van D1 en de uitvinding is hetzelfde (laag
transgehalte). D1 is CPA. Op te lossen probleem: reactietijd van D1 is te lang.
Oplossing: gebruik van combinatie van nanodeeltjes en polymeer. Resultaat:
behoud van goed transgehalte (ongeveer 20%; examples 4,5,7,8) terwijl
reactietijd verkort is tot 15-35 minuten. D1 heeft lange reactietijd (3-4 uur),
ook bij toevoegen PVP. Dit betekent dat de nu gebruikte nanodeeltjes tot een
voordeel leiden.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-top: 12.0pt;">
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">D2 openbaart gebruik van nanodeeltjes en het feit dat
daarmee korte (niet-gespecificeerde) reactietijden worden verkregen. D2 noemt
geen transgehalte en geen gebruik van PVP. De combinatie van D1 en D2 leidt dus
eventueel tot het gebruik van nanodeeltjes, niet tot de combinatie met PVP
omdat D1 geen enkel voordeel noemt van het gebruik daarvan en D2 geen
aanleiding geeft tot het gebruik daarvan.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-top: 12.0pt;">
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">Het gebruik van D2 als CPA lijkt me ook verdedigbaar en
zelf gemakkelijker (gemeenschappelijk doel korte reactietijd; Probleem: hoog
transgehalte. Dit gehalte is in D2 onbekend, maar Examples 2 en 6 kunnen
worden gezien als voorbeelden van D2 waaruit blijkt dat dit gehalte bij D2 hoog
is). De toevoeging van polymeer wordt op geen enkele manier gesuggereerd in D2
en ook niet in combinatie met D1 omdat D1 juist openbaart dat het gebruik van
PVP geen enkel nut heeft. Omdat het op het examen niet ongebruikelijk is om
voorbeelden uit de aanvraag te herleiden tot voorbeelden van de SvT (of omgekeerd)
zou het goed kunnen zijn dat de examencommissie wil uitgaan van D2.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-top: 12.0pt;">
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">Oorspronkelijke conclusie 2 kan worden geschrapt. Uit de
aanvraag blijkt dat dit bereik alleen maar een voorkeursbereik is en dat poriën
in feite helemaal niet nodig zijn [014].</span></div>
<div class="MsoNormal" style="margin-top: 12.0pt;">
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">Basis voor de geamendeerde conclusies is gemakkelijk uit
de aanvraag te halen ([010], [015], [016] eventueel in combinatie met examples
2, 3 en 6).<o:p></o:p></span><br />
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;"><br /></span>
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">Tom Beetz</span><br />
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;"><br /></span>
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;"></span><br />
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<br /></div>
<span lang="NL" style="color: #1f497d; mso-ansi-language: NL;">
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span lang="NL" style="color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-ansi-language: NL; mso-fareast-font-family: "Times New Roman";">(English translation)<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">The Exam 2014 B looks relatively simple.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">On the basis of the claims as proposed by client, the following
claims can be submitted:<br />
<!--[if !supportLineBreakNewLine]--><br />
<!--[endif]--><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm; margin-left: 18.2pt; margin-right: 0cm; margin-top: 0cm; text-indent: -17.5pt;">
<span lang="NL" style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">1. Process for the
hydrogenation of edible oils in the presence of hydrogen a catalyst comprising
a solid support, precious metal nanoparticles having an average particle size
of 1 to 12 nm, according to ASTM 99999/2000, and at least 0.1 wt% of a polymer
containing a heterocyclic group having at least one heteroatom.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span lang="NL" style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">2. The process
according to claim 1 wherein the heterocyclic group is a side group of the
polymer.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span lang="NL" style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">3. Process according
to claim 1 or 2 wherein the heteroatom is nitrogen.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span lang="NL" style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">4. Process according
to claim 1 to 3 wherein the polymer is polyvinylpyrrolidone.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span lang="NL" style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">5. Process according
to claims 1 to 4, wherein the edible oil is fish oil.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span lang="NL" style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">6. Process according
to claims 1 to 4, wherein the edible oil is soybean oil.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<a href="" name="more"></a><span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;"><br />
D1 relates to a process of obtaining low trans contents. PVP is used, however
only as a filter aid. PVP has no influence on the reaction. The particle size
of the noble metal has not been disclosed. The reaction time is 3-4 hours.<br />
D2 relates to a process using nano-particles. The reaction time is short.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">The purpose of D1 and the invention is the same (low trans
contents). </span><span lang="NL" style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">D1 is CPA. </span><span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">Problem to be solved: reaction
time of D1 is too long. Solution: use of combination of nano-particles and
polymer. Result: maintenance of good trans content (about 20%; examples
4,5,7,8) whereas reaction time has been shortened to 15-35 minutes. D1 has long
reaction times (3-4 hours), also when PVP is added. This means that the nano-particles
of the invention lead to an advantage.</span><span style="color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">D2 discloses the use of nano-particles and the fact that its use
leads to short (unspecified) reaction times. D2 does not disclose trans
contents and does not mention the use of PVP. The combination of D1 and D2 can
lead to the use of nano-particles, but not to the combination with PVP since D1does
not mention any advantage for the use thereof and D2 does not suggest its use.</span><span style="color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">Starting with D2 as CPA seems also defendable and is even easier (common
purpose: short reaction times; problem: high trans contents. This content is
not known from D2 but Examples 2 and 6 can be considered as examples of D2
which show that this content is high for D2). In D2 the addition of polymer has
not been suggested in any manner and neither in combination with D1, because D1
discloses on the contrary that PVP is of
no use at all. Since it is not uncommon in the qualifying examination to use
examples of the application as examples of the prior art (or vice versa) is it
very well possible that the examination committee considers this as the correct
inventive step argument..</span><span style="color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">Original claim 2 can be deleted. The application shows that this is
only a preferred range and that pores are not really necessary [014].</span><span style="color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;">Basis for the amendments can easily be obtained from the
application ([010], [015], [016] possibly in combination with examples 2, 3 and
6).</span><span style="color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman";"><br />
</span><span style="border: 1pt none windowtext; font-family: inherit, serif; font-size: 10pt; padding: 0cm;"><br />
Tom Beetz</span><span style="color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman";"><o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: 15.6pt; margin-bottom: .0001pt; margin-bottom: 0cm;">
<span style="color: black; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman";"><br />
<!--[if !supportLineBreakNewLine]--><br />
<!--[endif]--></span><o:p></o:p></div>
</span></div>
Unknownnoreply@blogger.comtag:blogger.com,1999:blog-4115187698733166691.post-81860954376808861122014-03-03T12:20:00.002+01:002014-03-05T15:46:44.890+01:00Paper B ch available<div style="margin-bottom: .0001pt; margin: 0cm;">
Paper B ch is now available on our website via<span class="apple-converted-space"> </span><a href="http://www.deltapatents.com/data/uploads/downloads/B2014-Ch%20EN%20(scan).pdf" target="_blank">this link</a>.<o:p></o:p></div>
<div style="margin: 0cm 0cm 0.0001pt;">
<br /></div>
Our comments will be posted in due course.Roel van Woudenberghttp://www.blogger.com/profile/15823355175016282250noreply@blogger.com